AKT plays a pivotal role in the acquisition of resistance to 5-fluorouracil in human squamous carcinoma cells

Molecular Medicine Reports

Volumn 2, Issue 4, 2009, Pages 609-613

  You, Fukka ^a   Aoki, Kenta ^a   Ito, Yatsuji ^a   Nakashima, Shigeru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 fluorouracil; Akt; Drug resistance; ERK; Squamous cell carcinoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FLUOROURACIL; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UO 126;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER THERAPY; CELL DEATH; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 69549097832     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000145     Document Type: Article

References (20)

1. Longley DB, Harkin DP and Johnston PG: 5-Fluorouracil: mechanism of action and clinical strategies. Nat Rev Cancer 3: 330-338, 2003.
2. Pratt S, Shepard RL, Kandasamy RA, Johnston PA, Perry W III and Dantzig AH: The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther 4: 855-863, 2005. (Pubitemid 40767130)
3. Zhu H, Guo W, Zhang L, Davis JJ, Teraishi F, Wu S, Cao X, Daniel J, Smythe WR and Fang B: Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells. Mol Cancer Ther 4: 451-456, 2005. (Pubitemid 40443930)
4. Graidist P, Phongdara A and Fujise K: Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity. J Biol Chem 279: 40868-40875, 2004 (Pubitemid 39287685)
5. Datta SR, Brunet A and Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
6. Erhardt P, Schremser EJ and Cooper GM: B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol Cell Biol 19: 5308-5315, 1999. (Pubitemid 29339890)
7. Khwaja A, Rodrigues-Vicana P, Wennstrom S, Warne PH and Downward J: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997. (Pubitemid 27226215)
8. Marais R, Light Y, Paterson HF and Marshall CJ: Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 14: 3136-3145, 1995.
9. Aoki K, Ogawa T, Ito Y and Nakashima S: Cisplatin activates survival signals in UM-SCC-23 squamous cell carcinoma and these signal pathways are amplified in cisplatin-resistant squamous cell carcinoma. Oncol Rep 11: 375-379, 2004.
10. You F, Osawa Y, Hayashi S and Nakashima S: Immediate early gene IEX-1 induces astrocytic differentiation of U87-MG human glioma cells. J Cell Biochem 100: 256-265, 2007. (Pubitemid 44958195)
11. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689, 1997. (Pubitemid 27464966)
12. Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M and McCubrey JA: Effect of RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene 22: 2478-2492, 2003. (Pubitemid 36560731)
13. An Q, Robins P, Lindahl T and Barnes DE: 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res 67: 940-945, 2007.
14. Gilkes DM, Chen L and Chen J: MDMX regulation of p53 response to ribosomal stress. EMBO J 25: 5614-5625, 2006. (Pubitemid 44847201)
15. Wang W, Cassidy J, O'Brien V, Ryan KM and Collie-Duguid E Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells. Cancer Res 64: 8167-8176, 2004. (Pubitemid 39491752)
16. De Angelis PM, Svendsrud DH, Kravik KL and Stokke T: Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 5: 20, 2006.
17. Yoshimura S, Banno Y, Nakashima S, Takenaka K, Sakai H, Nishimura Y, Sakai N, Shimizu S, Eguchi Y, Tsujimoto Y and Nozawa Y: Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death: Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J Biol Chem 268: 6921-6927, 1998. (Pubitemid 28160357)
18. Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N and Nozawa Y: Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 19: 3508-3520, 2000. (Pubitemid 30487448)
19. Jin W, Wu L, Liang K, Liu B, Lu Y and Fan Z: Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells. Br J Cancer 89: 185-191, 2003. (Pubitemid 36897956)
20. Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997, 2001. (Pubitemid 32720961)